Growth Metrics

Repligen (RGEN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $172.0 million.

  • Repligen's Operating Expenses rose 570.18% to $172.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $707.1 million, marking a year-over-year increase of 1363.42%. This contributed to the annual value of $669.6 million for FY2024, which is 1452.03% up from last year.
  • According to the latest figures from Q3 2025, Repligen's Operating Expenses is $172.0 million, which was up 570.18% from $168.5 million recorded in Q2 2025.
  • In the past 5 years, Repligen's Operating Expenses ranged from a high of $204.0 million in Q4 2024 and a low of $106.5 million during Q1 2021
  • In the last 5 years, Repligen's Operating Expenses had a median value of $149.1 million in 2021 and averaged $149.3 million.
  • In the last 5 years, Repligen's Operating Expenses soared by 8197.51% in 2021 and then plummeted by 781.69% in 2023.
  • Quarter analysis of 5 years shows Repligen's Operating Expenses stood at $149.1 million in 2021, then decreased by 7.49% to $137.9 million in 2022, then rose by 13.65% to $156.7 million in 2023, then soared by 30.18% to $204.0 million in 2024, then fell by 15.72% to $172.0 million in 2025.
  • Its Operating Expenses stands at $172.0 million for Q3 2025, versus $168.5 million for Q2 2025 and $162.6 million for Q1 2025.